TY - JOUR
T1 - Energy metabolism, proteotoxic stress and age-related dysfunction
T2 - protection by carnosine
AU - Hipkiss, Alan R.
PY - 2011/8
Y1 - 2011/8
N2 - This review will discuss the relationship between energy metabolism, protein dysfunction and the causation and modulation of age-related proteotoxicity and disease. It is proposed that excessive glycolysis, rather than aerobic (mitochondrial) activity, could be causal to proteotoxic stress and age-related pathology, due to the generation of endogenous glycating metabolites: the deleterious role of methylglyoxal (MG) is emphasized. It is suggested that TOR inhibition, exercise, fasting and increased mitochondrial activity suppress formation of MG (and other deleterious low molecular weight carbonyl compounds) which could control onset and progression of proteostatic dysfunction. Possible mechanisms by which the endogenous dipeptide, carnosine, which, by way of its putative aldehyde-scavenging activity, may control age-related proteotoxicity, cellular dysfunction and pathology, including cancer, are also considered. Whether carnosine could be regarded as a rapamycin mimic is briefly discussed.
AB - This review will discuss the relationship between energy metabolism, protein dysfunction and the causation and modulation of age-related proteotoxicity and disease. It is proposed that excessive glycolysis, rather than aerobic (mitochondrial) activity, could be causal to proteotoxic stress and age-related pathology, due to the generation of endogenous glycating metabolites: the deleterious role of methylglyoxal (MG) is emphasized. It is suggested that TOR inhibition, exercise, fasting and increased mitochondrial activity suppress formation of MG (and other deleterious low molecular weight carbonyl compounds) which could control onset and progression of proteostatic dysfunction. Possible mechanisms by which the endogenous dipeptide, carnosine, which, by way of its putative aldehyde-scavenging activity, may control age-related proteotoxicity, cellular dysfunction and pathology, including cancer, are also considered. Whether carnosine could be regarded as a rapamycin mimic is briefly discussed.
KW - advanced glycation
KW - AGEs
KW - aging
KW - carnosine
KW - glycolysis
KW - methylglyoxal
KW - proteotoxicity
UR - http://www.scopus.com/inward/record.url?scp=81855198862&partnerID=8YFLogxK
U2 - 10.1016/j.mam.2011.10.004
DO - 10.1016/j.mam.2011.10.004
M3 - Article
C2 - 22020113
AN - SCOPUS:81855198862
SN - 0098-2997
VL - 32
SP - 267
EP - 278
JO - Molecular Aspects of Medicine
JF - Molecular Aspects of Medicine
IS - 4-6
ER -